Novanta Finalizes $1.2 Billion Cash Acquisition of Runway Buyer LLC, Broadening Industrial Tech Portfolio

Acquisition Closing and Deal Structure

Novanta Inc., a Canadian corporation, completed its purchase of Runway Buyer LLC through its Delaware subsidiary, Novanta Medical Technologies Corp., with Novanta Corporation as the intermediate parent company. The transaction closed on July 23, 2026, following the Equity Purchase Agreement initially disclosed on June 8, 2026. The acquisition involved buying all issued and outstanding limited liability company interests in Runway Buyer from Runway Midco, LLC, the seller.

The deal was structured through a multi-party agreement to integrate the acquired assets into Novanta’s existing operations. Details from the June 8, 2026 Form 8-K filing were incorporated by reference in this announcement. This acquisition finalizes a transaction announced earlier in the year and sets the stage for integrating Runway Buyer into Novanta’s operating divisions.

Financial Terms and Payment Details

At closing on July 23, 2026, Novanta paid approximately $1.2 billion in cash consideration to the seller, subject to customary post-closing adjustments related to cash, working capital, debt, and transaction expenses of Runway Buyer as of the closing date. These adjustments follow standard acquisition practices based on the target’s financial condition at closing.

In addition to the upfront payment, Novanta committed to a $250 million milestone payment due on or before January 8, 2027. This earnout extends the total consideration to $1.45 billion, making it one of Novanta’s largest capital deployments. Specific conditions for the milestone payment beyond the due date were not disclosed.

Debt Financing and Credit Facility Usage

Novanta’s intermediate parent entity borrowed $616 million under its revolving credit facility and delayed draw term loan facility per its Fourth Amended and Restated Credit Agreement. These borrowings occurred on July 22, 2026, one day before closing, aligning the debt financing with the transaction completion. The remaining acquisition funds were covered by Novanta’s cash reserves.

The debt under both credit facilities matures in June 2030 and may be repaid early without penalty, providing Novanta flexibility to refinance or repay as business conditions allow. This structure allows a four-year period for the acquired business to contribute to cash flow and debt servicing.

Pro Forma Debt and Leverage Position

Following the July 22, 2026 borrowings, Novanta’s consolidated debt totaled $854.7 million, reflecting the sum of new borrowings and existing obligations. This figure offers investors insight into the company’s leverage after financing the acquisition.

Pre-borrowing debt levels were not disclosed, preventing precise calculation of leverage increase due to the acquisition. The filing also lacks pro forma leverage ratios or interest coverage metrics; however, these financial details will be provided within 71 days in required filings.

Customary Adjustments and Conditions

The closing payment is subject to standard post-closing adjustments based on Runway Buyer’s financial condition at closing, including working capital, cash balances, debt, and transaction expenses. The Purchase Agreement filed on June 8, 2026, details these adjustment mechanisms and is incorporated by reference here.

Regulatory Filings and Future Disclosures

Novanta will file audited financial statements of Runway Buyer and pro forma financial information as an amendment to this report within 71 calendar days, by early September 2026. These filings will provide detailed historical financial performance and the acquisition’s impact on Novanta’s consolidated results.

Certain exhibits, including the July 27, 2026 press release, are furnished for informational purposes and are not deemed "filed" under the Securities Exchange Act, limiting liability under Section 18. The company signed this disclosure on July 27, 2026, marking the official announcement date.

Strategic Timing and Market Context

The acquisition announcement came four days after closing, consistent with standard corporate communication practices. The timing reflects coordination with market conditions and internal protocols. Investors should consider this transaction within the broader market and management’s capital allocation strategy.

The filing does not provide forward-looking guidance on financial contributions, integration plans, or synergies. For strategic insights, investors should review the July 27, 2026 press release and subsequent investor communications.

Integration and Operational Outlook

Runway Buyer was acquired as a complete limited liability company, with all interests transferred to Novanta Medical Technologies Corp. This suggests Novanta plans to operate Runway Buyer as a distinct subsidiary initially. The use of intermediate parent entities and holding company structures is typical for managing debt and operational considerations in leveraged transactions.

Details on integration progress, management changes, or operational restructuring will likely be disclosed in future earnings reports, investor presentations, or regulatory filings. Historical acquisition practices may indicate expected integration timelines.

Credit Agreement Terms and Refinancing Options

The Fourth Amended and Restated Credit Agreement governs the revolving credit and delayed draw term loan facilities used for this acquisition. The June 2030 maturity allows a four-year window for refinancing or repayment. Borrowings can be repaid at any time without prepayment penalties, offering borrower-friendly flexibility.

Interest rates, fees, covenants, and other credit terms were not disclosed in this filing. Investors seeking these details should consult prior credit agreement filings or public debt disclosures. The split between amounts drawn under each facility was also not specified.